Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Publication

Publications

Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases

Title
Surface-modified lipid nanocarriers for crossing the blood-brain barrier (BBB): A current overview of active targeting in brain diseases
Type
Article in International Scientific Journal
Year
2023
Authors
Teixeira, MI
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Lopes, CM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maria Helena Amaral
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page Without ORCID
Paulo Costa
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Journal
Vol. 221
ISSN: 0927-7765
Publisher: Elsevier
Other information
Authenticus ID: P-00X-G73
Abstract (EN): The blood-brain barrier (BBB) restricts the access of therapeutic agents to the brain, complicating the treatment of neurological diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), multiple sclerosis (MS), glioma, etc. To overcome this limitation and improve drug delivery to the central nervous system (CNS), the potential of nanocarriers, including lipid-based nanosystems, has been explored. Through active targeting, the surface of the nanocarriers can be modified with ligands that interact with the BBB, enhancing their uptake and penetration across the brain endothelium by different physiological mechanisms, such as receptor-or transporter-mediated transcytosis. This review seeks to provide an overview of active targeting in brain delivery, while highlighting the potential of functionalized lipid nanocarriers to treat brain diseases. Therefore, in the first sections, we discuss the importance of active targeting in CNS drug delivery, present the different ligands commonly used for functionalization, as well as summarize the state of the art of the most recent and relevant studies of surface-modified lipid nanosystems developed for neurological disorders. Lastly, challenges hindering clinical translation are discussed, and critical insights and future perspectives outlined. Although some limita-tions have been identified, it is expected that in the upcoming years these nanosystems will be an established approach.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 24
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Recent Developments in Microfluidic Technologies for Central Nervous System Targeted Studies (2020)
Another Publication in an International Scientific Journal
Teixeira, MI; Maria Helena Amaral; Paulo Costa; Lopes, CM; Lamprou, DA
Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases (2020)
Article in International Scientific Journal
Teixeira, MI; Lopes, CM; Maria Helena Amaral; Paulo Costa

Of the same journal

Nanotechnological carriers for cancer chemotherapy: The state of the art (2015)
Another Publication in an International Scientific Journal
Estanqueiro, M; Maria Helena Amaral; Conceicao, J; Sousa Lobo, JMS
3D-printed biosurfactant-chitosan antibacterial coating for the prevention of silicone-based associated infections (2023)
Article in International Scientific Journal
Narciso F; Cardoso S; Monge N; Lourenço M; Victor Martin; Duarte N; Catarina Santos ; Gomes PS; Ana Bettencourt
UV-C driven reduction of nanographene oxide opens path for new applications in phototherapy (2024)
Article in International Scientific Journal
Silva, FALS; Timochenco, L; Costa Almeida, R; Fernandes, JR; Santos, SG; Magalhães, F. D.; Artur Pinto
Topical co-delivery of methotrexate and etanercept using lipid nanoparticles: A targeted approach for psoriasis management (2017)
Article in International Scientific Journal
Ferreira, M; Barreiros, L; Marcela A Segundo; Torres, T; Selores, M; Costa Lima, SAC; Salette Reis
The potential advantages of using a poly(HPMA) brush in urinary catheters: effects on biofilm cells and architecture (2020)
Article in International Scientific Journal
Patrícia Alves; Luciana Gomes; Mariia Vorobii; César Rodriguez-Emmenegger; Filipe Mergulhão

See all (77)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-07-08 at 03:42:54 | Privacy Policy | Personal Data Protection Policy | Whistleblowing